Paper180276
Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni.
Haese WH and 1 other. J Pharmacol Exp Ther, 1976. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni. Papers, record 180276. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/180276
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hycanthone | Major topic |
| Nitroquinolines | Major topic |
| Oxamniquine | Major topic |
| Schistosomiasis | Major topic |
| Schistosomicides | Major topic |
| Thioxanthenes | Major topic |
| Animals | |
| Carcinoma, Hepatocellular | |
| Female | |
| Indazoles | |
| Liver | |
| Liver Neoplasms | |
| Mice | |
| Schistosoma mansoni |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41155906 | Development of a Novel Compound Effective Against Juvenile, Adult, and Drug-Resistant Schistosoma Species. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41155906 | PubMed |
| 35976333 | Clustered Regularly Interspaced Short Palindromic Repeats/ CRISPR associated protein 9-mediated editing of Schistosoma mansoni genes: Identifying genes for immunologically potent drug and vaccine development. | Rev Soc Bras Med Trop | 2022 | https://conductscience.org/library/papers/35976333 | PubMed |
| 32810153 | An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans. | PLoS Negl Trop Dis | 2020 | https://conductscience.org/library/papers/32810153 | PubMed |
| 30017854 | Schistosomal liver fibrosis and hepatocellular carcinoma - case series of patients submitted to liver transplantation. | Braz J Infect Dis | 2018 | https://conductscience.org/library/papers/30017854 | PubMed |
| 3267457 | Comparison of the Ames assay and the induction of sister chromatid exchanges: results with ten pharmaceuticals and five selected agents. | Cell Biol Toxicol | 1986 | https://conductscience.org/library/papers/3267457 | PubMed |
| 3130351 | Hepatoma formation in ddY mice with chronic schistosomiasis japonica. | Jpn J Cancer Res | 1988 | https://conductscience.org/library/papers/3130351 | PubMed |
| 317254 | Multicentre trials of praziquantel in human schistosomiasis: design and techniques. | Bull World Health Organ | 1979 | https://conductscience.org/library/papers/317254 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/180276
GET https://conductscience.org/api/papers/v1/180276/authors